These findings provide new insights into the molecular mechanisms underlying ACh-driven metastasis and suggest that targeting the Glo1/MG-H1 pathway and OPN could offer a novel strategy to interfere with the progression of prostate cancers where cholinergic signaling plays a pivotal role before it becomes clinically aggressive and potentially uncurable. Here, GLO1 is linked to Familial prostate cancer.